Kokuyo Camlin Limited (KOKUYOCMLN.NS)
Mumbai, IN
Kokuyo Camlin Limited, an India-based enterprise, specializes in the production and distribution of a broad spectrum of stationery, artistic materials, and scholastic items. Its extensive product portfolio is carefully segmented to serve diverse user groups. For students, the company provides a comprehensive selection of school supplies, including various writing instruments like pencils, pens, fountain pens, and mechanical pencils; an array of coloring tools such as crayons, color pencils, brush pens, sketch pens, poster colors, and watercolors; creative essentials like clay, dough, and adhesives; and organizational products like notebooks, drawing books, and geometry sets. Office professionals can access key office consumables, including correction pens, gum and paste products, markers, and general office accessories. Artists and designers are catered to with a wide range of fine art supplies, encompassing artist-grade acrylics, oils, and watercolors, alongside pastels, drawing inks, charcoal, canvases, brushes, and specialized painting mediums. Furthermore, hobbyists find a variety of craft materials, such as 3D glitters, specialized colors (fluid acrylics, sparkle colors), cone-liners, and dedicated hobby brushes and mediums. These products are sold under the established Camel and Camlin brand names. While primarily focused on the Indian market, Kokuyo Camlin also extends its reach through exports to SAARC countries, the Middle East, the Far East, and Japan. Established in 1931, the company was initially known as Camlin Limited before rebranding to Kokuyo Camlin Limited in 2012. Headquartered in Mumbai, India, it operates as a subsidiary of the Japanese conglomerate, Kokuyo Co., Ltd.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.81% | +1.39% | -3.89% | +4.90% | -8.06% | -4.20% | -20.95% | -21.12% | +41.58% | +17.09% | +416.63% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Business Equipment & Supplies: +4.2%+5.7% ★ Q1'26: +13.1% (vs Q1'25)
-
EPS growth Business Equipment & Supplies: +9.0%+333.3% ★ Q1'26: -32.6% (vs Q1'25)
-
FCF margin FCF growth · Business Equipment & Supplies: +11.3%+2.7% Q1'26: +26.1% (vs Q1'25)
-
EBIT margin Business Equipment & Supplies: +8.5%+4.5% Q1'26: +2.1% (vs Q1'25)
-
ROIC Business Equipment & Supplies: +6.9%+7.6% ★ Q1'26: +4.0% (vs Q1'25)
-
Share dilution Business Equipment & Supplies: +0.1%-1.1% ★ Q1'26: -2.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Business Equipment & Supplies: -1.46×0.63× Q1'26: 0.85× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2020 actual |
Mar 2021 actual |
Mar 2026 1 Rev. Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|
| Revenue |
6.34B
est: 7.62B (-16.8%)
|
4.03B
est: 8.53B (-52.8%)
|
7.80B
7.80B – 7.80B
-8.6% YoY
|
8.87B
8.87B – 8.87B
+13.7% YoY
|
9.75B
9.75B – 9.75B
+10.0% YoY
|
| EBITDA |
337.50M
est: 417.39M (-19.1%)
|
89.48M
est: 458.27M (-80.5%)
|
504.86M
504.86M – 504.86M
+10.2% YoY
|
574.00M
574.00M – 574.00M
+13.7% YoY
|
631.36M
631.36M – 631.36M
+10.0% YoY
|
| EBIT |
144.72M
est: 183.99M (-21.3%)
|
-94.55M
est: 202.01M (-146.8%)
|
294.48M
294.48M – 294.48M
+45.8% YoY
|
334.81M
334.81M – 334.81M
+13.7% YoY
|
368.26M
368.26M – 368.26M
+10.0% YoY
|
| Net Income |
43.56M
est: 174.97M (-75.1%)
|
-146.18M
est: 202.96M (-172.0%)
|
—
— – —
-100.0% YoY
|
130.46M
130.46M – 130.46M
|
341.21M
341.21M – 341.21M
+161.5% YoY
|
| SGA |
266.55M
est: 455.00M (-41.4%)
|
128.12M
est: 499.56M (-74.4%)
|
692.76M
692.76M – 692.76M
+38.7% YoY
|
787.63M
787.63M – 787.63M
+13.7% YoY
|
866.34M
866.34M – 866.34M
+10.0% YoY
|
| EPS |
0.43
est: 1.72 (-75.1%)
|
-1.46
est: 2.01 (-172.7%)
|
—
— – —
-100.0% YoY
|
1.30
1.30 – 1.30
|
3.40
3.40 – 3.40
+161.5% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-25 | B+ | 3/5 | 3/5 | 3/5 | 4/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-22 | B+ | 3/5 | 3/5 | 3/5 | 4/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-21 | B+ | 3/5 | 3/5 | 3/5 | 4/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-20 | B+ | 3/5 | 3/5 | 3/5 | 4/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-19 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-18 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-15 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Satish Veerappa | MD & Director | 26M | male |
| Takashi Itoguchi | Executive Director | 6M | male |
| Manik Salunkhe | Vice President of Technical | — | male |
| Nilesh Choudhary | Chief Financial Officer | — | male |
| Rishi Kakar | Chief Marketing & Strategy Officer | — | male |
| Srinivasa Kaza | Vice President of Sales | — | male |
| Takashi Ohashi | President - Research & Development | — | male |
| Chandrashekhar Deshmukh | Chief Human Resources Officer | — | male |
| Vipul Bhoy | Compliance Officer & Company Secretary | — | male |
| D. Dandekar | Founder | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for KOKUYOCMLN.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
